Albumin Market Report 2025 (Global Edition)

Global Albumin Market Report 2025 Market Size Split by Type (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), by Application (Therapeutics, Drug Formulation and Vaccine, Component of M...

Albumin Market Report Description

We have various report editions of Albumin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Albumin Market Insights Video

Competitive Landscape of the Albumin

Market participants are also undertaking various organic or inorganic strategic approaches to strengthen and expand their Worldwide footprint, with significant market developments including new Material portfolios, contractual deals, mergers and acquisitions, capital expenditure, higher investments, and strategic alliances with other organizations. Businesses are also coming up with marketing strategies such as digital marketing, social media influencing, and content marketing to increase their scope of profit earnings. Because of automation and technological advancement, businesses compete fiercely to deliver innovative products.

• In July 2023, Kedrion Biopharma, a global biopharmaceutical firm that produces therapeutic products derived from plasma, stated that it would be expanding its human serum albumin products into the Chinese market to treat uncommon disorders.

(Source:www.kedrion.com/kedrions-global-portfolio-expands-to-china/)

• June 2023: Sartorius AG  and Cell and Gene Treatment Catapult (CGT Catapult) worked together to explore using albumin-based solutions from the firm for advanced treatment applications, such as the production of viral vectors.

(Source:www.sartorius.com/en/applications/biopharmaceutical-manufacturing/regenerative-medicine/gene-therapy)

• American Regent, Inc. announced the introduction of paclitaxel protein-bound granules for injectable solution (Albumin-Bound), an Abraxane substitute, in May 2023.

(Source:americanregent.com/media/3426/pp-pt-us-0003_pr_-v018-_08feb2023.pdf)

Top Companies Market Share in Albumin Industry: (In no particular order of Rank)

• Albumedix Ltd.
• Biotest AG
• Celgene Corporation (Bristol-Myers Squibb Company)
• CSL Limited
• Grifols SA
• HiMedia Laboratories
• Medxbio Pte Ltd.
• Merck KGaA
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Thermo Fisher Scientific Inc.
• Ventria Bioscience Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

North America dominated the market in 2023. It accounted for around 40% of the Worldwide revenue

According to Cognitive Market Research, North America dominated the market in 2023. It accounted for around 40% of the Worldwide revenue, owing to the high frequency of long-term illnesses in the area, such as diabetes, renal problems, and liver ailments, which call for regular albumin-based monitoring and treatment. Furthermore, North America boasts a highly developed healthcare infrastructure and performs many surgical procedures yearly, contributing to increased albumiAlbuminritical and surgical care use. With significant R&D expenditure, technological developments in biopharmaceuticals have also helped broaden albumin uses, further propelling the market. Consumer trust is increased by regulatory backing from organizations like the FDA, which guarantees product quality and safety.

APAC is the fastest-growing category during the projected timeframe due to the high demand for these goods. The development of manufacturing facilities in China, rising R&D expenditures, and the strong uptake of medicinal goods are the main drivers of the regional market's growth. Growing government spending and R&D for creating technologically superior items are some of the factors driving the market's growth in this area.

The current report Scope analyzes Albumin Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Albumin Market Analysis

According to Cognitive Market Research, the Worldwide Albumin market size was estimated at USD 5124.2 Million out of which North America held the major market of more than 40% of the Worldwide revenue with market size of USD 2049.68 million in 2023 and will grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030 high frequency of long-term illnesses in the area, such as diabetes, renal problems, and liver ailments, which call for regular albumin-based monitoring and treatment. Furthermore, North America boasts a highly developed healthcare infrastructure and performs many surgical procedures yearly, contributing to increased albumiAlbuminritical and surgical care use. With significant R&D expenditure, technological developments in biopharmaceuticals have also helped broaden albumin uses, further propelling the market. Consumer trust is increased by regulatory backing from organizations like the FDA, which guarantees product quality and safety. According to Cognitive Market Research, Human Serum Albumin held the major market share over the forecast period due to the increasing incidence of chronic liver and renal illnesses requiring routine albumin level monitoring and therapy, a significant contributing factor. In conclusion, the North American Albumin market is thriving due to the high frequency of long-term illnesses in the area, such as diabetes, renal problems, and liver ailments, which call for regular albumin-based monitoring and treatment.

Europe Albumin Market Analysis

According to Cognitive Market Research, with a market value of USD 5124.2 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030, Europe accounted for a share of over 30% of the Worldwide market size of USD 1537.26 million as a result of new product introductions, the adoption of significant activities such alliances and acquisitions, and increased investments. The biopharmaceutical sector's increased medication research and development efforts are expected to drive the albumin market. The German market for Albumin is the fastest growing area, while the UK market has the biggest market share. Recombinant AlbumiAlbumine is the fastest-growing category over the forecast period due to its high uniformity, high purity, and lack of animal-derived components, which will drive this segment's expansion. In addition, strategic moves, including acquisitions by major industry participants, are anticipated to propel the segment's expansion in the upcoming years. In conclusion, the European Albumin market thrives due to new product introductions, the adoption of significant activities such as alliances and acquisitions, and increased investments.

Asia Pacific Albumin Market Analysis

According to Cognitive Market Research, the Worldwide Albumin market size was estimated at USD 5124.2 Million, out of which Asia Pacific held the market of more than 22% of the Worldwide revenue with a market size of USD 1178.57 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030 due to the high demand for these goods. The development of manufacturing facilities in China, rising R&D expenditures, and the strong uptake of medicinal goods are the main drivers of the regional market's growth. Growing government spending and R&D for creating technologically superior items are some of the factors driving the market's growth in this area. According to Cognitive Market Research, Therapeutics holds a prominent market share due to several converging causes. The most important of them is the rise of chronic illnesses, including diabetes, renal disease, and liver disease, which make albumin-based therapies necessary to control blood volume and protein levels. In conclusion, the Asia Pacific Albumin market shows significant growth due to the prevalence of blood-related illnesses in humans, such as blood infections, would rise, driving up demand for albumin

South America Albumin Market Analysis

According to Cognitive Market Research, the Worldwide Albumins market size was estimated at USD 5124.2 Million, out of which the Latin America market has more than 5% of the Worldwide revenue with market size of USD 256.21 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030 to develop as a result of the start of R&D projects and the growing penetration of plasma fractionation facilities, which support the manufacture of these goods. According to Cognitive Market Research, hospitals and clinics hold a prominent market share growing due to several significant factors. The number of surgical procedures using albumin management increases the demand in hospitals and clinics. Albumin product use has increased due to improvements in healthcare infrastructure funded by public and private sources and aims to improve patient outcomes and care quality. In conclusion, the Latin American Albumin market exhibits steady growth, driven by government initiatives and legislation to accept new technology trends and advances in the health sector.

Middle East Albumin Market Analysis

According to Cognitive Market Research, the Worldwide Albumin market size was estimated at USD 5124.2 Million, out of which the Middle East and Africa held the major market of more than 2% of the Worldwide revenue with market size of USD 102.48 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030 as there are now more hospitals, clinics, and healthcare institutions using albumin products as a consequence of significant governmental and private investments in healthcare. According to Cognitive Market Research, Others (research) are the fastest-growing category over the forecast period due to rising investments in R&D and clinical trials for medication development and the rising prevalence of numerous rare ailments and life-threatening diseases. In conclusion, the MEA (Middle East and Africa) albumin market exhibits growth potential due to more hospitals, clinics, and healthcare institutions using albumin products due to significant governmental and private investments in healthcare.

Albumin Market Analysis

Albumin System Type Segment Analysis

According to Cognitive Market Research, Human Serum Albumin held the major market share over the forecast period due to the increasing incidence of chronic liver and renal illnesses requiring routine albumin level monitoring and therapy, a significant contributing factor. Demand is also fuelled by the growing number of surgical procedures that require human serum albumin to control fluid balance. Technological developments in biotechnology have simplified the process of producing and purifying human serum albumin, increasing its accessibility and affordability. As a result, it is now more often used in medical and non-medical applications, including vaccine stabilization and medicine development.

Recombinant AlbumiAlbumine is the fastest-growing category over the forecast period due to its high uniformity, high purity, and lack of animal-derived components, which will drive this segment's expansion. In addition, strategic moves, including acquisitions by major industry participants, are anticipated to propel the segment's expansion in the upcoming years.

• Human Serum Albumin 
• Bovine Serum Albumin 
• Recombinant Albumin

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Albumin Industry. Request a Free Sample PDF!

Albumin System Application Segment Analysis

According to Cognitive Market Research, hospitals and clinics hold a prominent market share growing due to several significant factors. The number of surgical procedures using albumin management increases the demand in hospitals and clinics. Albumin product use has increased due to improvements in healthcare infrastructure funded by public and private sources and aims to improve patient outcomes and care quality.

Pharmaceutical and Biotechnology is the fastest-growing category over the forecast period; it is expected to grow faster due to the increasing use of Albumine and the creation of novel therapeutic solutions. Expanding these recombinant goods' application areas through increased R&D efforts may lead to greater sector growth throughout the projection period.

• Therapeutics
• Drug Formulation and Vaccine 
• Component of Media
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Albumin End User Segment Analysis

According to Cognitive Market Research, Therapeutics holds a prominent market share due to several converging causes. The most important of them is the rise of chronic illnesses, including diabetes, renal disease, and liver disease, which make albumin-based therapies necessary to control blood volume and protein levels. The need for Albumin is due to the growing number of surgical operations, particularly in the aging global population, as Albumin is frequently required to maintain fluid balance during surgeries. The production of customized albumin formulations optimized for drug delivery systems has been made possible by advancements in biotechnological research, hence extending the protein's medicinal potential.

Others are the fastest-growing category over the forecast period as rising investments in R&D and clinical trials for medication development and the rising prevalence of rare ailments and life-threatening diseases.

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Institutes

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion